课题基金 / 基金详情

High field NMR spectrometer for chemical biology research

High field NMR spectrometer for chemical biology research
用于化学生物学研究的高场核磁共振波谱仪
批准号:
360010-2008
负责人:
Mittermaier, Anthony
金额:
$10.93万
依托单位:
依托单位国家:
加拿大
项目类别:
Research Tools and Instruments - Category 1 (<$150,000)
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31

项目摘要

项目成果

Mittermaier, Anthony的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most pharmaceuticals are small organic compounds that exert their influence by specifically interacting with a biological macromolecule such as a protein or nucleic acid and altering its function. The diversity of prospective therapeutic agents is enormous; the number small molecules that can exist in theory vastly exceeds the number that can ever be synthesized and tested. Thus our ability to control living systems chemically is limited primarily by the difficulty of uncovering appropriate molecules within the immense universe of possibilities. The field of Chemical Biology seeks to meet this challenge by studying the rules that govern macromolecule/drug interactions and how these interactions lead ultimately to a physiological effect. Two critical steps in this process are the synthesis of novel compounds and detailed characterization of their interactions with biological targets. In order for these steps to be successful, researchers must be able to elucidate the structures of the molecules in question with atomic resolution.Nuclear Magnetic Resonance (NMR) spectroscopy is an extremely powerful technique for determining the three-dimensional structures of organic compounds, biological macromolecules, and their complexes. We are requesting NMR equipment that will increase the availability and versatility of this vital tool in our research. The new infrastructure will be used to develop new synthetic routes to biologically important classes of compounds, improve chemically-modified oligonucleotides with potential applications against cancer, inflammatory, and infectious diseases, refine inhibitors of a bacterial drug-resistance enzyme, generate natural products and natural product hybrids, and study the fundamental thermodynamic principles underlying protein/drug interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA dynamics in biology and technology
  • 批准号:
    RGPIN-2022-03242
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.52万
  • 财政年份:
    2022
  • 负责人:
    Mittermaier, Anthony
  • 依托单位:
Binding Mechanisms and Conformational Equilibria in Biomacromolecular Interactions
  • 批准号:
    RGPIN-2014-05776
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.93万
  • 财政年份:
    2021
  • 负责人:
    Mittermaier, Anthony
  • 依托单位:
Binding Mechanisms and Conformational Equilibria in Biomacromolecular Interactions
  • 批准号:
    RGPIN-2014-05776
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.93万
  • 财政年份:
    2020
  • 负责人:
    Mittermaier, Anthony
  • 依托单位:
Binding Mechanisms and Conformational Equilibria in Biomacromolecular Interactions
  • 批准号:
    RGPIN-2014-05776
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.93万
  • 财政年份:
    2019
  • 负责人:
    Mittermaier, Anthony
  • 依托单位:
国内基金
海外基金
适用膜蛋白-配体复合物结构测定的1H和19F距离约束检测的固体NMR方法研究
  • 批准号:
    JCZRYB202500181
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
NMR-CRISPR体系的构建及在肝癌ctDNA及miRNA联合检测中的应 用
基于 NMR 指纹特征图谱与代谢组学结合模式追踪土家药 血筒果实中抗类风湿关节炎的效应物质
  • 批准号:
    2024JJ6347
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    苏维
  • 依托单位:
基于ResNet-CNN和2D1H.13C HSQC NMR技术的多基原藏药'阿布卡'品质整合评控体系构建
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    杜欢
  • 依托单位: